Results 51 to 60 of about 45,247 (265)

BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians. [PDF]

open access: yes, 2020
B-Cell Lymphoma-extra-large (BCL-xL) is involved in longevity and successful aging, which indicates a role for BCL-xL in cell survival pathway regulation. Beyond its well described role as an inhibitor of apoptosis by preventing cytochrome c release, BCL-
Borrás, Consuelo   +7 more
core   +1 more source

Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro. [PDF]

open access: yesPLoS ONE, 2013
Migration and invasion of malignant cells are prerequisites for cancer progression and metastasis. The Bcl-2 family of proteins consists of about 25 members and has been extensively studied in the context of apoptosis.
Bruno Christian Koehler   +9 more
doaj   +1 more source

BCL-XL overexpression promotes tumor progression-associated properties article [PDF]

open access: yes, 2017
By using human melanoma and glioblastoma cell lines and their derivative BCL-XL overexpressing clones, we investigated the role of BCL-XL in aggressive features of these two tumor histotypes.
Alessandrini, Gabriele   +9 more
core   +2 more sources

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells

open access: yesHaematologica, 2023
BCL-XL and BCL-2 are key anti-apoptotic proteins and validated cancer targets. 753B is a novel BCL-XL/BCL-2 proteolysis targeting chimera (PROTAC) that targets both BCL-XL and BCL-2 to the von Hippel-Lindau (VHL) E3 ligase, leading to BCLX L/BCL-2 ...
Yannan Jia   +19 more
doaj   +1 more source

BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer [PDF]

open access: yes, 2022
The heterogeneous therapy response observed in colorectal cancer is in part due to cancer stem cells (CSCs) that resist chemotherapeutic insults. The anti-apoptotic protein BCL-XL plays a critical role in protecting CSCs from cell death, where its ...
Atencia Taboada, Lidia   +6 more
core   +1 more source

The Structural Biology of Bcl-xL [PDF]

open access: yesInternational Journal of Molecular Sciences, 2019
Interactions between the pro-survival and pro-apoptotic members of the Bcl-2 family of proteins dictate whether a cell lives or dies. Much of our knowledge of the molecular details of these interactions has come from biochemical and structural studies on the pro-survival protein Bcl-xL. The first high-resolution structure of any Bcl-2 family member was
Erinna F. Lee, W. Douglas Fairlie
openaire   +3 more sources

High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia. [PDF]

open access: yes, 2016
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a predictive biomarker of disease progression in many malignancies, including imatinib-treated chronic myeloid leukemia (CML).
Butterworth, M.   +7 more
core   +1 more source

The Effects of Thymoquinone on Viability, and Anti-apoptotic Factors (BCL-XL, BCL-2, MCL-1) in Prostate Cancer (PC3) Cells: An In Vitro and Computer-Simulated Environment Study [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2019
Purpose: Since active plant ingredients can induce apoptosis in many tumors, in this study we evaluate the apoptotic effects of thymoquinone (TQ) on PC3 cells.
Javad Saffari_Chaleshtori   +3 more
doaj   +1 more source

Regulation of Bcl-xl Channel Activity by Calcium [PDF]

open access: yesJournal of Biological Chemistry, 1998
Recent studies have demonstrated that the anti-apoptotic proteins, Bcl-2 and Bcl-xl, with the carboxyl-terminal hydrophobic domain removed, form cation-selective channels in the lipid bilayer reconstitution system. However, the regulatory properties of these channels are unknown.
Jianjie Ma   +4 more
openaire   +3 more sources

Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma

open access: yesiScience, 2023
Summary: Extranodal natural killer/T cell lymphoma, nasal type (ENKTL) is an aggressive lymphoid malignancy with a poor prognosis and lacks standard treatment. Targeted therapies are urgently needed.
Chuanxu Liu   +15 more
doaj  

Home - About - Disclaimer - Privacy